Key result
Individual batches of hiPSC-CMs can express non-cardiac sarcolemmal ion channels (BKCa), resulting in oscillating afterdepolarizations that are stopped by iberiotoxin (observed in 7 of 16 batches).
Why the study?
It remains unclear whether human induced pluripotent stem cell-derived cardiomyocytes express all cardiac ion channels at physiological levels or potentially express non-cardiac ion channels.
Case Report
Individual batches of hiPSC-CMs can express non-cardiac ion channels (BKCa) causing artifactual action potential oscillations, indicating a need for screening before use in drug research.
hiPSC-CM batches require screening for BKCa artifacts before electrophysiological assays; leaves open standardization of differentiation protocols for reliable research models.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) represent an unlimited source of human CMs that could be a standard tool in drug research. However, there is concern whether hiPSC-CMs express all cardiac ion channels at physiological level and whether they might express non-cardiac ion channels. In a control hiPSC line, we found large, “noisy” outward K+ currents, when we measured outward potassium currents in isolated hiPSC-CMs. Currents were sensitive to iberiotoxin, the selective blocker of big conductance Ca2+-activated K+ current (IBK,Ca). Seven of 16 individual differentiation batches showed a strong initial repolarization in the action potentials (AP) recorded from engineered heart tissue (EHT) followed by very early afterdepolarizations, sometimes even with consecutive oscillations. Iberiotoxin stopped oscillations and normalized AP shape, but had no effect in other EHTs without oscillations or in human left ventricular tissue (LV). Expression levels of the alpha-subunit (KCa1.1) of the BKCa correlated with the presence of oscillations in hiPSC-CMs and was not detectable in LV. Taken together, individual batches of hiPSC-CMs can express sarcolemmal ion channels that are otherwise not found in the human heart, resulting in oscillating afterdepolarizations in the AP. HiPSC-CMs should be screened for expression of non-cardiac ion channels before being applied to drug research.
No takes yet. Share an insight, caveat, or question.
Horváth et al. (2020) conducted a case report in hiPSC-Cardiomyocytes. Iberiotoxin was evaluated on Presence of oscillations and action potential shape. Individual batches of hiPSC-CMs can express non-cardiac sarcolemmal ion channels (BKCa), resulting in oscillating afterdepolarizations that are stopped by iberiotoxin (observed in 7 of 16 batches).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: